OpenAI researcher Miles Wang is leaving to launch an AI drug discovery startup, with Lightspeed in talks to lead a funding round reportedly near $200 million at a $2 billion valuation. Wang disputed the figures but offered no corrections. The move follows similar ventures including Chai Discovery, co-founded by Josh Meier, and Google DeepMind spinout Isomorphic Labs, reflecting investor interest in AI for life sciences.
No score is assigned. Sources and their independence are shown in the citation chain below.